Ginkgo Bioworks Holdings, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ginkgo Bioworks Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • Ginkgo Bioworks Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $712M, a 14.6% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $712M -$121M -14.6% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $833M +$250M +42.9% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $583M +$439M +305% Dec 31, 2021 10-K 2024-02-29
Q4 2020 $144M +$39.1M +37.3% Dec 31, 2020 10-K 2023-03-13
Q4 2019 $105M +$30.2M +40.6% Dec 31, 2019 10-K 2022-03-29
Q4 2018 $74.5M Dec 31, 2018 8-K 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.